Binder profile
ZINC111459735
Virtual-screening candidate from ZINC.
Bound to: PA1155 — ribonucleotide-diphosphate reductase subunit beta
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC111459735- UniProt (similar protein)
P69924- Tanimoto
- 0.836
- Target protein
- PA1155
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 481.2
- LogP ≤ 5 -1.20
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 249.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1cn([C@@H]2C[C@H](N)[C@H](CO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=OCc1cn([C@@H]2C[C@H](N)[C@H](CO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O
InChI=1S/C10H18N3O13P3/c1-5-3-13(10(15)12-9(5)14)8-2-6(11)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8H,2,4,11H2,1H3,(H,19,20)(H,21,22)(H,12,14,15)(H2,16,17,18)/t6-,7-,8-/m0/s1InChI=1S/C10H18N3O13P3/c1-5-3-13(10(15)12-9(5)14)8-2-6(11)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8H,2,4,11H2,1H3,(H,19,20)(H,21,22)(H,12,14,15)(H2,16,17,18)/t6-,7-,8-/m0/s1
FGYGYHFEBIMMKO-FXQIFTODSA-NFGYGYHFEBIMMKO-FXQIFTODSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- TTP
- Homolog
- P69924
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC111459735 →
- ZINC ZINC20 ZINC111459735 →
- UniProt UniProt P69924 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC111459735”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1155.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).